ISDA

Deposition Date 2013-06-20

Release Date 2013-08-07

Last Version Date 2023-12-20

Entry Detail

PDB ID:

4BUL

Keywords:

ISOMERASE

Title:

Novel hydroxyl tricyclics (e.g. GSK966587) as potent inhibitors of bacterial type IIA topoisomerases

Biological Source:

Source Organism:

STAPHYLOCOCCUS AUREUS (Taxon ID: 1280)
SYNTHETIC CONSTRUCT (Taxon ID: 32630)

Host Organism:

ESCHERICHIA COLI

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.60 Å

R-Value Free:

0.18

R-Value Work:

0.14

R-Value Observed:

0.14

Space Group:

P 61

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:DNA GYRASE SUBUNIT B, DNA GYRASE SUBUNIT A
Gene (Uniprot):gyrB, gyrA
Mutations:YES
Chain IDs:A, B (auth: C)
Chain Length:692
Number of Molecules:2
Biological Source:STAPHYLOCOCCUS AUREUS

UniProt ID:P66937,Q99XG5 Pfam ID:PF01751, PF00986, PF00521 EC:5.6.2.2

Polymer Type:polydeoxyribonucleotide
Molecule:5'-D(*TP*GP*TP*GP*CP*GP*GP*TP*GP*TP*AP*CP*CP*TP *AP*CP*GP*GP*CP*T)-3'
Chain IDs:C (auth: E), E (auth: G)
Chain Length:20
Number of Molecules:2
Biological Source:SYNTHETIC CONSTRUCT

Polymer Type:polydeoxyribonucleotide
Molecule:5'-D(*AP*GP*CP*CP*GP*TP*AP*GP*GP*TP*AP*CP*AP*CP *CP*GP*CP*AP*C)-3'
Chain IDs:D (auth: F), F (auth: H)
Chain Length:20
Number of Molecules:2
Biological Source:SYNTHETIC CONSTRUCT

Ligand Molecules

AE8

Primary Citation

Novel Hydroxyl Tricyclics (E.G., Gsk966587) as Potent Inhibitors of Bacterial Type Iia Topoisomerases.

Miles, T.J, Hennessy, A.J, Bax, B, Brooks, G, Brown, B.S, Brown, P, Cailleau, N, Chen, D, Dabbs, S, Davies, D.T, Esken, J.M, Giordano, I, Hoover, J.L, Huang, J, Jones, G.E, Kusalakumari Sukmar, S.K, Spitzfaden, C, Markwell, R.E, Minthorn, E.A, Rittenhouse, S, Gwynn, M.N, Pearson, N.D, Bax, B.D, Chan, P.F, Eggleston, D.S, Fosberry, A, Gentry, D.R, Gorrec, F, Giordano, I, Hann, M.M, Hennessy, A, Hibbs, M, Huang, J, Jones, E, Jones, J, Brown, K.K, Lewis, C.J, May, E.W, Saunders, M.R, Singh, O, Spitzfaden, C.E, Shen, C, Shillings, A, Theobald, A.J, Wohlkonig, A, Pearson, N.D, Gwynn, M.N.Show

Bioorg.Med.Chem.Lett. 23 5437 ? (2013)

PMID: 23968823 DOI: 10.1016/J.BMCL.2013.07.013

Abstact

During the course of our research to find novel mode of action antibacterials, we discovered a series of hydroxyl tricyclic compounds that showed good potency against Gram-positive and Gram-negative pathogens. These compounds inhibit bacterial type IIA topoisomerases. Herein we will discuss structure-activity relationships in this series and report advanced studies on compound 1 (GSK966587) which demonstrates good PK and in vivo efficacy properties. X-ray crystallographic studies were used to provide insight into the structural basis for the difference in antibacterial potency between enantiomers.

Legend

Protein

Chemical

Disease

Primary Citation of related structures